Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-03-06 @ 7:47 AM
Study NCT ID:
NCT02117934
Status:
COMPLETED
Last Update Posted:
2019-03-20
First Post:
2014-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
Sponsor:
Dynavax Technologies Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-15
First Submit QC Date:
None
Study First Post Date:
2014-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-08
Results First Submit QC Date:
None
Results First Post Date:
2018-01-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-02-07
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-03-18
Last Update Post Date:
2019-03-20
Last Update Post Date Type:
ACTUAL